259.04USD+4.03%Mkt Cap: —P/E: 46.961d ago
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap—
Enterprise Value54.33B $
Revenue (TTM)16.98B $
Gross Profit5.60B $
Net Income (TTM)1.38B $
Revenue/Share100.70 USD
Last Price259.04 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees94.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS46266C1053
Valuation
P/E (Trailing)46.96
P/E (Forward)—
PEG—
EV/EBITDA17.82
EV/Revenue3.20
P/S—
P/B6.47
EPS (TTM)5.54
EPS (Forward)—
52W Range
238.8397% of range259.74
52W High259.74 USD
52W Low238.83 USD
Profitability
Gross Margin32.97%
Oper. Margin13.03%
EBITDA Margin17.95%
Profit Margin8.10%
ROE22.82%
ROA5.06%
Growth
Revenue Growth8.70%
Earnings Growth-0.60%
Cash Flow & Leverage
Operating CF2.82B $
CapEx (TTM)—
FCF Margin12.66%
FCF Yield—
Net Debt14.17B $
Net Debt/EBITDA4.65
Balance Sheet
Debt/Equity257.98
Current Ratio0.71
Quick Ratio0.62
Book Value/Sh37.49 USD
Cash/Share12.64 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.202.31M
Float156.25M
Insiders1.09%
Institutions103.46%
Technical
SMA 50229.03 (+13.1%)
SMA 200214.61 (+20.7%)
Beta1.18
S&P 52W Chg20.80%
Avg Vol (30d)790
Avg Vol (10d)394
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—